Via News Release
“MINNEAPOLIS (April 19, 2016) – MyMeds, a pioneer and leader in medication adherence technology for employers, PBMs and health plans, announced today that Pete Clagett, has joined the company as Chief Executive Officer (CEO). Clagett is charged with driving the company’s growth and strategic direction. Both Clagett and Founder and Chief Medical Officer, Rajiv R. Shah, MD, will serve on the MyMeds Board of Directors.”
“We are thrilled Pete is joining MyMeds,” said Shah. “He is a perfect complement to our team, bringing invaluable PBM and health plan background and experience to help MyMeds scale our operations and technology, better understand and serve our clients’ needs and, most importantly, improve health outcomes of patients.”
Clagett was most recently the SVP of Integrated Cost of Care and Specialty at Prime Therapeutics and was a member of their Executive Leadership Team. While at Prime, he was responsible for managing nearly $20 billion in annual prescription drug spend across all segments of Prime’s commercial and government business. Prior to Prime, Clagett served as CEO of US Script, a PBM owned by Centene. Clagett joined US Script from WellPoint (now Anthem) and previously was at GlaxoSmithKline.
“Pete has an incredible track record of success. A proven industry leader, he is passionate about this opportunity to improve health outcomes.” said Anne deBruin Sample, lead Director of the CEO Search Committee. “Pete rounds out a team that has done a fantastic job of creating a digital platform that will revolutionize medication adherence. With Pete, MyMeds will be even better positioned to help organizations effectively address spiraling healthcare costs. This is an exciting time for MyMeds and all of its partners.”
“I’m excited to join MyMeds and its excellent team,” said Clagett. “MyMeds’ innovative clinical approach and technology-driven solution uniquely addresses the issues of medication non-adherence, consumer engagement, and their effects on healthcare organizations and patients. With our partnerships, I believe we are well positioned to become the next great digital health services company.”
MyMeds is a digital medication adherence company that uses technology to improve healthcare. Headquartered in Minneapolis, MyMeds serves self-insured employers, PBMs and health plans. Follow the company at twitter.com/MyMedsInc or visit www.my-meds.com.